Holzer & Holzer, LLC said investors can still seek lead plaintiff appointments in shareholder class action lawsuits involving ARS Pharmaceuticals, Alarum Technologies, Blaize Holdings, Black Rock Coffee Bar, Embecta and Peabody Energy. The suits allege materially false or misleading statements or omissions of material facts tied respectively to ARS's timeline for expanded insurance coverage for neffy with CVS Caremark, Alarum subsidiary NetNut's effect on legal exposure and business prospects, Blaize's allegedly improper revenue recognition, Black Rock Coffee's expansion strategy, Embecta's weakness in the U.S. pen needle market and its effect on guidance and second-quarter 2026 results, and Peabody Energy's Centurion mine ramp-up and anticipated growth. Lead plaintiff deadlines disclosed in the releases are Aug. 17, 2026 for Black Rock Coffee, Aug. 24, 2026 for Peabody Energy and Oct. 5, 2026 for ARS Pharmaceuticals, while investors in all six matters were directed to contact Corey D. Holzer, Esq. about their legal rights.